Nearly $4 million. That's what NYC's public hospitals handed Palantir since last fall, just to walk away from a contract laced with privacy red flags. Meanwhile, across the pond, the UK's NHS is sleepwalking into deeper ties with the same controversial AI player.
Over 3,000 Google workers revolted in 2018 against AI for drone kills. Fast-forward: that tech's now in US ops against Iran, courtesy of a stubborn Marine colonel.
Palantir just landed a high-stakes trial with the UK's FCA, probing sensitive financial crime intel for £30,000 a week. But insiders fear it's a Trojan horse for deeper data dominance — and ethical pitfalls.
Palantir techies flood FCA headquarters, terabytes of financial secrets lighting up their screens. Britain's power brokers just handed the AI giant another key to the kingdom.
Everyone figured Palantir's big reveal would be more commercial cash cows. Nope—it's all Iron Man suits for the battlefield, with CEOs playing soldier.